Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
A Edelman, E Micks, ML Motu'apuaka… - Cochrane Database …, 2014 - cochranelibrary.com
Background The avoidance of menstruation through continuous or extended (greater than
28 days) administration of combination hormonal contraceptives (CHCs) has gained …
28 days) administration of combination hormonal contraceptives (CHCs) has gained …
Body mass index and sexual behavior
…, SM Harvey, MD Nichols, AB Edelman - Obstetrics & …, 2008 - journals.lww.com
OBJECTIVE: To characterize the relationship between body mass index and sexual behavior,
including sexual orientation, age at first intercourse, ever having had sex with a male …
including sexual orientation, age at first intercourse, ever having had sex with a male …
Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion
…, PH Bednarek, MD Nichols, JT Jensen, AB Edelman - Contraception, 2009 - Elsevier
BACKGROUND: The aim of the study was to identify barriers associated with the failure to
return for delayed intrauterine device (IUD) insertion postabortion. STUDY DESIGN: This study …
return for delayed intrauterine device (IUD) insertion postabortion. STUDY DESIGN: This study …
[HTML][HTML] Association between menstrual cycle length and coronavirus disease 2019 (COVID-19) vaccination: a US cohort
A Edelman, ER Boniface, E Benhar, L Han… - Obstetrics & …, 2022 - journals.lww.com
OBJECTIVE: To assess whether coronavirus disease 2019 (COVID-19) vaccination is
associated with changes in cycle or menses length in those receiving vaccination as compared …
associated with changes in cycle or menses length in those receiving vaccination as compared …
Contraception selection, effectiveness, and adverse effects: a review
S Teal, A Edelman - Jama, 2021 - jamanetwork.com
Importance Many women spend a substantial proportion of their lives preventing or planning
for pregnancy, and approximately 87% of US women use contraception during their lifetime…
for pregnancy, and approximately 87% of US women use contraception during their lifetime…
Progestin‐only contraceptives: effects on weight
…, S Ramesh, M Chen, A Edelman… - Cochrane Database …, 2016 - cochranelibrary.com
Background Progestin‐only contraceptives (POCs) are appropriate for many women who
cannot or should not take estrogen. POCs include injectables, intrauterine contraception, …
cannot or should not take estrogen. POCs include injectables, intrauterine contraception, …
Hormonal contraceptives for contraception in overweight or obese women
…, C Otterness, C Westhoff, A Edelman… - Cochrane Database …, 2016 - cochranelibrary.com
Background Obesity has reached epidemic proportions around the world. Effectiveness of
hormonal contraceptives may be related to metabolic changes in obesity or to greater body …
hormonal contraceptives may be related to metabolic changes in obesity or to greater body …
Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women
AB Edelman, E Schaefer, A Olson, L Van Houten… - Contraception, 2011 - Elsevier
BACKGROUND: This study was conducted to examine the effects of prophylactic misoprostol
prior to intrauterine device (IUD) placement in nulliparous women. STUDY DESIGN: …
prior to intrauterine device (IUD) placement in nulliparous women. STUDY DESIGN: …
The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review
MK Baldwin, AB Edelman - Journal of adolescent health, 2013 - Elsevier
Repeat pregnancy within 2 years of a previous birth or abortion occurs in approximately 35%
of recently pregnant female adolescents. The majority of these pregnancies are classified …
of recently pregnant female adolescents. The majority of these pregnancies are classified …
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity
AB Edelman, NE Carlson, G Cherala, MY Munar… - Contraception, 2009 - Elsevier
BACKGROUND: This study was conducted to determine whether increased body mass index
(BMI) affects oral contraceptive (OC) pharmacokinetics and suppression of hypothalamic–…
(BMI) affects oral contraceptive (OC) pharmacokinetics and suppression of hypothalamic–…